Author

A. Tabachnikova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Research Focus:cell type annotation· 4 Approach:experimental assay· 4 Research Focus:cell-cell communication· 3 Research Focus:differential expression· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Assay:CITE-seq· 1

Frequent Co-Authors

E. Kenigsberg· 4 shared A. H. Rahman· 3 shared C. Chang· 3 shared J. LeBerichel· 3 shared M. Merad· 3 shared S. Gnjatic· 3 shared T. U. Marron· 3 shared A. Lansky· 2 shared

Activity by Year

2020-2022 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

E. Kenigsberg

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Intratumoral mregDC and CXCL13 T helper niches enable local differentiation of CD8 T cells following PD-1 blockade

A. Magen, P. Hamon, N. Fiaschi, L. Troncoso, E. Humblin, D. D'souza, T. Dawson, M. D. Park, J. Kim, S. Hamel, M. Buckup, C. Chang, A. Tabachnikova, H. Schwartz, N. Malissen, , Merad

The paper identifies intratumoral niches involving mregDC and CXCL13+ Th cells that support CD8 T cell differentiation following PD-1 blockade in HCC patients.

bioRxiv · Jun 22, 2022 · PreprintImmunology

Spatial positioning and matrix programs of cancer-associated fibroblasts promote T cell exclusion in human lung tumors

J. A. Grout, P. Sirven, A. M. Leader, S. Maskey, E. Hector, I. Puisieux, F. Steffan, E. Cheng, N. Tung, M. Maurin, R. Vaineau, L. Karpf, M. Plaud, M. Casanova-Acebes, A. Tabachnikova, , H. Salmon

The paper identifies two CAF subsets in human lung tumors that promote T cell exclusion through distinct matrix programs and spatial organization.

bioRxiv · Jan 20, 2022Cancer Biology

Shift of lung macrophage composition is associated with COVID-19 disease severity and recovery

S. T. Chen, M. D. Park, D. M. Del Valle, M. Buckup, A. Tabachnikova, N. W. Simons, K. Mouskas, B. Lee, D. Geanon, D. D'Souza, T. Dawson, R. Marvin, K. Nie, R. Thompson, Z. Zhao, , M. Merad

This study identifies shifts in lung macrophage composition linked to COVID-19 severity and recovery, suggesting therapeutic strategies targeting macrophage function.

bioRxiv · Jan 11, 2022 · PreprintImmunology

No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination

A. Lu-Culligan, A. Tabachnikova, M. Tokuyama, H. J. Lee, C. Lucas, V. Silva Monteiro, M. C. Muenker, S. Mohanty, J. Huang, I. Kang, C. Dela Cruz, S. Farhadian, M. Campbell, I. Yildirim, A. Shaw, , A. Iwasaki

This study investigates whether COVID-19 mRNA vaccination affects pregnancy outcomes or induces anti-syncytin-1 antibodies, finding no evidence of fetal defects or increased antibody levels.

bioRxiv · Dec 7, 2021 · PreprintImmunology

CITEseq analysis of non-small-cell lung cancer lesions reveals an axis of immune cell activation associated with tumor antigen load and TP53 mutations

A. M. Leader, J. A. Grout, C. Chang, B. Maier, A. Tabachnikova, L. Walker, A. Lansky, J. LeBerichel, N. Malissen, M. Davila, J. Martin, G. Magri, K. Tuballes, Z. Zhoa, F. Petralia, , M. Merad

The paper analyzes CITEseq data from NSCLC lesions to identify an immune cell activation module linked to tumor antigen load and TP53 mutations.

bioRxiv · Jul 16, 2020 · PreprintImmunology